Human embryonic stem cells (hESCs) were first discovered thirteen years ago. Since then, they have shown incredible potential for therapeutic applications in conditions ranging from Alzheimer's disease to diabetes — but no studies examining their effects in humans had ever been published. Yesterday, however, that all changed.
Seeded on Tue Jan 24, 2012 12:03 PM EST

- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
Marking one of the biggest milestones for the cells since their discovery, researchers yesterday published the first-ever results of a clinical trial that involved the transplantation of hESCs into the eyes of patients suffering from progressive forms of blindness. And the preliminary results look very good.
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



